|
|
Line 18: |
Line 18: |
| | | |
| ===Biobrick characterization=== | | ===Biobrick characterization=== |
− | ====LB culture of electro-transformed BL21 cells [[Team:Paris_Saclay/Notebook/July/13#Biobrick_characterization|(Cf)]]==== | + | ====LB culture of electro-transformed BL21 cells ([[Team:Paris_Saclay/Notebook/July/13#Biobrick_characterization|cf: protocol]])==== |
| ''By Mathilde '' | | ''By Mathilde '' |
| | | |
− | Each transformation : pclTAA + K1372001, pcl_TAG + K1372001 and pcl_Tq + K1372001 was added to 3mL of LB and one or two antibiotics. | + | Each transformation : BL21|pcl_TAA + K1372001, BL21|pcl_TAG + K1372001 and BL21|pcl_Tq + K1372001 was added to 3mL of LB and one or two antibiotics. |
| | | |
| Three conditions were tested for each transformation : | | Three conditions were tested for each transformation : |
Line 28: |
Line 28: |
| * 15µL of Chloramphenicol (30µg/mL) + 5 µL of Streptomycin (50µg/mL) | | * 15µL of Chloramphenicol (30µg/mL) + 5 µL of Streptomycin (50µg/mL) |
| | | |
− | Cultures were put in incubation at 37°c, 180 rpm. | + | Cultures were put in incubation at 37°C, 180 rpm. |
| | | |
| ===Visualization=== | | ===Visualization=== |
Revision as of 15:32, 25 July 2016